Traders cheered Aurobindo's in-line performance by sending the stock nearly 4 percent higher. But they punished Sun Pharma for missing Street estimates across the board by sending the stock down over 6 percent. CNBC-TV18's Ekta Batra and Archana Shukla crunch the numbers.
first published: May 31, 2016 09:54 pm
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty rangebound on monthly expiry day | Closing Bell
Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell
Nifty Slips Below 26,100 Amid Sluggish Trade, Midcaps Struggle; IT Lends Support | Closing Bell Live
Live: Can Nifty reach its all-time high levels this week? | Opening Bell
